Examination of bacterial inhibition using a catalytic DNA

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Qu, Long ^a,b   Ali, M Monsur ^b   Aguirre, Sergio D ^b   Liu, Hongxia ^a   Jiang, Yuyang ^a   Li, Yingfu ^b   Leng, Fenfei ^c  

^a TSINGHUA UNIVERSITY   (China)

^b MCMASTER UNIVERSITY   (Canada)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BACTERIAL PROTEIN; CHLORAMPHENICOL; DEOXYRIBOZYME; FLUORESCENT DYE; POLYMYXIN B; RFD EC1 PROTEIN; TETRACYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; MOLECULAR PROBE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BIOLOGICAL MONITORING; CONTROLLED STUDY; DRUG SCREENING; ESCHERICHIA COLI; FLUORESCENCE ANALYSIS; GROWTH INHIBITION; INTERMETHOD COMPARISON; LIMIT OF DETECTION; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR PROBE; NONHUMAN; OPTICAL DENSITY; PROTEIN CLEAVAGE; PROTEIN TARGETING; COMPARATIVE STUDY; DRUG EFFECTS; ENZYME ASSAY; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; PROCEDURES;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS);

ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; DNA, CATALYTIC; ENZYME ASSAYS; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MOLECULAR PROBES;

EID: 84919800838     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115640     Document Type: Article

References (64)

1. Rubin PH (2004) The FDA's antibiotic resistance. Regulation 27: 34-37.
2. Kolář M, Urbanek K, Lá tal T (2001) Antibiotic selective pressure and development of bacterial resistance. Int J Antimicrob Agents 17: 357-363.
3. McGowan JE (1983) Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 5: 1033-1048.
4. Porco TC, Gao D, Scott JC, Shim E, Enanoria WT, et al. (2012) When does overuse of antibiotics become a tragedy of the commons? PloS One 7: e46505.
5. Napolitano F, Izzo MT, Di Giuseppe G, Angelillo IF, Group CW (2013) Evaluation of the Appropriate Perioperative Antibiotic Prophylaxis in Italy. PloS One 8: e79532.
6. Napolitano F, Izzo MT, Di Giuseppe G, Angelillo IF (2013) Public Knowledge, Attitudes, and Experience Regarding the Use of Antibiotics in Italy. PloS One 8: e84177.
7. McCutcheon A, Ellis S, Hancock R, Towers G (1992) Antibiotic screening of medicinal plants of the British Columbian native peoples. J Ethnopharmacol 37: 213-223.
8. Mossialos E, Morel CM, Edwards S, Berenson J, Gemmill-Toyama M, et al. (2010) Policies and incentives for promoting innovation in antibiotic research: European Observatory on Health Systems and Policies. WHO Publications. 72 p.
9. Sang Y, Blecha F (2008) Antimicrobial peptides and bacteriocins: Alternatives to traditional antibiotics. Anim Health Res Rev 9: 227-235.
10. Wimley WC, Hristova K (2011) Antimicrobial peptides: successes, challenges and unanswered questions. J Membr Biol 239: 27-34.
11. Mondhe M, Chessher A, Goh S, Good L, Stach JE (2014) Species-Selective Killing of Bacteria by Antimicrobial Peptide-PNAs. PloS One 9: e89082.
12. Dobson AJ, Purves J, Kamysz W, Rolff J (2013) Comparing Selection on S. aureus between Antimicrobial Peptides and Common Antibiotics. PloS One 8: e76521.
13. Erickson KL, Hubbard NE (2000) Probiotic immunomodulation in health and disease. J Nutr 130: 403S-409S.
14. Rea MC, Alemayehu D, Ross RP, Hill C (2013) Gut Solutions to a Gut Problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection. J Med Microbiol 62: 1369-1378.
15. Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, et al. (2000) The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 31: 1012-1017.
16. Wullt M, Hagslätt M-lJ, Odenholt I (2003) Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: A double-blind, placebo-controlled trial. Scand J of Infect Dis 35: 365-367.
17. Lawrence SJ, Korzenik JR, Mundy LM (2005) Probiotics for recurrent Clostridium difficile disease. J Med Microbiol 54: 905-906.
18. Bernet-Camard MF, Lievin V, Brassart D, Neeser JR, Servin AL, et al. (1997) The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol 63: 2747-2753.
19. La Ragione RM, Casula G, Cutting SM, Woodward MJ (2001) Bacillus subtilis spores competitively exclude Escherichia coli O78: K80 in poultry. Vet Microbiol 79: 133-142.
20. La Ragione RM, Woodward MJ (2003) Competitive exclusion by Bacillus subtilis spores of Salmonella enterica serotype Enteritidis and Clostridium perfringens in young chickens. Vet Microbiol 94: 245-256.
21. Guo X, Li D, Lu W, Piao X, Chen X (2006) Screening of Bacillus strains as potential probiotics and subsequent confirmation of the in vivo effectiveness of Bacillus subtilis MA139 in pigs. Antonie Van Leeuwenhoek 90: 139-146.
22. Vaseeharan B, Ramasamy P (2003) Control of pathogenic Vibrio spp. by Bacillus subtilis BT23, a possible probiotic treatment for black tiger shrimp Penaeus monodon. Lett Appl Microbiol 36: 83-87.
23. Bauer A, Kirby W, Sherris JC, turck, Turck M (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45: 493-496.
24. Reller LB, Weinstein M, Jorgensen JH, Ferraro MJ (2009) Antimicrobial susceptibility testing: A review of general principles and contemporary practices. Clin Infect Dis 49: 1749-1755.
25. Lazcka O, Campo F, Munoz FX (2007) Pathogen detection: A perspective of traditional methods and biosensors. Biosens Bioelectron 22: 1205-1217.
26. Lee SY, Lee J, Lee HS, Chang JH (2013) Rapid Pathogen Detection with Bacterial-assembled Magnetic Mesoporous Silica. Biosens Bioelectron 53: 123-128.
27. Che Y, Li Y, Slavik M (2001) Detection of Campylobacter jejuni in poultry samples using an enzymelinked immunoassay coupled with an enzyme electrode. Biosens Bioelectron 16: 791-797.
28. Do JS, Weigel KM, Meschke JS, Cangelosi GA (2014) Biosynthetic Enhancement of the Detection of Bacteria by the Polymerase Chain Reaction. PloS One 9: e86433.
29. Rathinakumar R, Walkenhorst WF, Wimley WC (2009) Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: The importance of interfacial activity. J Am Chem Soc 131: 7609-7617.
30. Rathinakumar R, Wimley WC (2010) High-throughput discovery of broad-spectrum peptide antibiotics. FASEB J 24: 3232-3238.
31. Marks JR, Placone J, Hristova K, Wimley WC (2011) Spontaneous membrane-translocating peptides by orthogonal high-throughput screening. J Am Chem Soc 133: 8995-9004.
32. Rathinakumar R, Wimley WC (2008) Biomolecular engineering by combinatorial design and highthroughput screening: small, soluble peptides that permeabilize membranes. J Am Chem Soc 130: 9849-9858.
33. Rausch JM, Wimley WC (2001) A high-throughput screen for identifying transmembrane pore-forming peptides. Anal Biochem 293: 258-263.
34. Coconnier MH, Lievin V, Hemery E, Servin AL (1998) Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 64: 4573-4580.
35. Coconnier MH, Lievin V, Bernet-Camard MF, Hudault S, Servin AL (1997) Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 41: 1046-1052.
36. Kaushik JK, Kumar A, Duary RK, Mohanty AK, Grover S, et al. (2009) Functional and probiotic attributes of an indigenous isolate of Lactobacillus plantarum. PLoS One 4: e8099.
37. Waters CM, Bassler BL (2005) Quorum sensing: cell-to-cell communication in bacteria. Annu Rev Cell Dev Biol 21: 319-346.
38. Cherif M, Loreau M (2007) Stoichiometric constraints on resource use, competitive interactions, and elemental cycling in microbial decomposers. Am Nat 169: 709-724.
39. Hibbing ME, Fuqua C, Parsek MR, Peterson SB (2009) Bacterial competition: surviving and thriving in the microbial jungle. Nat Rev Microbiol 8: 15-25.
40. Sovova K, Cepl J, Markos A, Spanel P (2013) Real time monitoring of population dynamics in concurrent bacterial growth using SIFT-MS quantification of volatile metabolites. Analyst 138: 4795- 4801.
41. Jacobsen CN, Nielsen VR, Hayford A, Møller P, Michaelsen K, et al. (1999) Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 65: 4949-4956.
42. Ranallo RT, Kaminski R, Baqar S, Dutta M, Lugo-Roman LA, et al. (2014) Oral administration of live Shigella vaccine candidates in rhesus monkeys show no evidence of competition for colonization and immunogenicity between different serotypes. Vaccine 32: 1754-1760.
43. Vital M, Hammes F, Egli T (2012) Competition of Escherichia coli O157 with a drinking water bacterial community at low nutrient concentrations. Water Res 46: 6279-6290.
44. Mei SH, Liu Z, Brennan JD, Li Y (2003) An efficient RNA-cleaving DNA enzyme that synchronizes catalysis with fluorescence signaling. J Am Chem Soc 125: 412-420.
45. Liu Z, Mei SH, Brennan JD, Li Y (2003) Assemblage of signaling DNA enzymes with intriguing metalion specificities and pH dependences. J Am Chem Soc 125: 7539-7545.
46. Tram K, Kanda P, Li Y (2013) Lighting Up RNA-Cleaving DNAzymes for Biosensing. J Nucleic Acids 2012: 958683.
47. Kandadai SA, Li Y (2005) Characterization of a catalytically efficient acidic RNA-cleaving deoxyribozyme. Nucleic Acids Res 33: 7164-7175.
48. Chiuman W, Li Y (2006) Evolution of high-branching deoxyribozymes from a catalytic DNA with a threeway junction. Chem Biol 13: 1061-1069.
49. Kandadai SA, Mok WW, Ali MM, Li Y (2009) Characterization of an RNA-cleaving deoxyribozyme with optimal activity at pH 5. Biochemistry 48: 7383-7391.
50. Ali MM, Aguirre SD, Lazim H, Li Y (2011) Fluorogenic DNAzyme probes as bacterial indicators. Angew Chem Int Ed 50: 3751-3754.
51. Tram K, Kanda P, Salena BJ, Huan S, Li Y (2014) Translating bacterial detection by DNAzymes into a litmus test. Angew Chem Int Ed 53: 12799-12802.
52. Aguirre SD, Ali MM, Kanda P, Li Y (2012) Detection of bacteria using fluorogenic DNAzymes. J Vis Exp: e3961.
53. Li Y (2011) Advancements in using reporter DNAzymes for identifying pathogenic bacteria at speed and with convenience. Future Microbiol 6: 973-976.
54. Aguirre SD, Ali MM, Salena BJ, Li Y (2013) A sensitive DNA enzyme-based fluorescent assay for bacterial detection. Biomolecules 3: 563-577.
55. Jones RN, Barry AL (1987) Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combination. J Clin Microbiol 25: 1920-1925.
56. Kwa A, Kasiakou SK, Tam VH, Falagas ME (2007) Polymyxin B: similarities to and differences from colistin (polymyxin E). Expert Rev Anti Infect Ther 5: 811-821.
57. Brown DA, Tsang JC (1978) Chemical and electrophoretic changes induced by polymyxin B on outer membrane components from Serratia marcescens. J Antibiot (Tokyo) 31: 603-609.
58. Misumi M, Tanaka N (1980) Mechanism of inhibition of translocation by kanamycin and viomycin: A comparative study with fusidic acid. Biochem Biophys Res Commun 92: 647-654.
59. Waxman DJ, Strominger JL (1983) Penicillin-binding proteins and the mechanism of action of betalactam antibiotics1. Annu Rev Biochem 52: 825-869.
60. Abranches J, Tijerina P, Avilés-Reyes A, Gaca AO, Kajfasz JK, et al. (2013) The Cell Wall-Targeting Antibiotic Stimulon of Enterococcus faecalis. PloS One 8: e64875.
61. Wisseman Jr C, Smadel J, Hahn F, Hopps H (1954) MODE OF ACTION OF CHLORAMPHENICOL I.: Action of Chloramphenicol on Assimilation of Ammonia and on Synthesis of Proteins and Nucleic Acids in Escherichia coli. J Bacteriol 67: 662.
62. Wolfe AD, Hahn FE (1965) Mode of action of chloramphenicol IX. Effects of chloramphenicol upon a ribosomal amino acid polymerization system and its binding to bacterial ribosome. Biochim Biophys Acta 95: 146-155.
63. Calvori C, Frontali L, Leoni L, Tecce G (1965) Effect of rifamycin on protein synthesis. Nature 207: 417-418.
64. Heaslet H, Harris M, Fahnoe K, Sarver R, Putz H, et al. (2009) Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim. Proteins 76: 706-717.